Invitae Corp
NYSE:NVTA
Intrinsic Value
The intrinsic value of one
NVTA
stock under the Base Case scenario is
4.5
USD.
Compared to the current market price of 1.29 USD,
Invitae Corp
is
Undervalued by 71%.
The Intrinsic Value is calculated as the average of the two valuation methods:
Fundamental Analysis
NVTA Profitability Score
Profitability Due Diligence
Invitae Corp's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
Score
Invitae Corp's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
NVTA Solvency Score
Solvency Due Diligence
Invitae Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Invitae Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Balance Sheet Decomposition
Invitae Corp
| Current Assets | 693M |
| Cash & Short-Term Investments | 547M |
| Receivables | 96.1M |
| Other Current Assets | 49.9M |
| Non-Current Assets | 1.3B |
| PP&E | 215M |
| Intangibles | 1B |
| Other Non-Current Assets | 33.2M |
| Current Liabilities | 108M |
| Accounts Payable | 14M |
| Accrued Liabilities | 78.8M |
| Other Current Liabilities | 15.3M |
| Non-Current Liabilities | 1.7B |
| Long-Term Debt | 1.6B |
| Other Non-Current Liabilities | 147M |
NVTA Capital Structure
Invitae Corp
| Market Capitalization | 317M USD | |
| Total Debt | 1.6B USD | |
| Minority Interest | 0 USD | |
| Preferred Equity | 0 USD | |
| Cash and Equivalents | 257M USD | |
| Short-Term Investments | 290M USD | |
| Enterprise Value | 1.4B USD | |
Wall St
Price Targets
NVTA Price Targets Summary
Invitae Corp
According to Wall Street analysts, the average 1-year price target for
NVTA
is 2.3 USD
with a low forecast of 1.01 USD and a high forecast of 4.2 USD.
Ownership
NVTA Insider Trading
Buy and sell transactions by insiders
During the last 12 months Invitae Corp insiders have not bought any shares, and sold 639k USD worth of shares. The last transaction was made on Mar 25, 2023 by Brida Thomas (General Counsel, Chief Compliance Officer and Secretary), who sold 3.7k USD worth of NVTA shares.
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
13.7k
USD
|
N/A
|
-13.7k
|
| 6 Months |
128k
USD
|
N/A
|
-128.3k
|
| 9 Months |
312k
USD
|
N/A
|
-312.4k
|
| 12 Months |
639k
USD
|
N/A
|
-638.7k
|
Shareholder Return
NVTA Return Decomposition
Main factors of price return
is not available
It is impossible to break down the market cap return as the net margin from 5 years ago is negative.
NVTA Price
Invitae Corp
| Average Annual Return | 52.19% |
| Standard Deviation of Annual Returns | 94.64% |
| Max Drawdown | -98% |
| Market Capitalization | 317M USD |
| Shares Outstanding | 259 455 008 |
| Percentage of Shares Shorted | 21.26% |
Company Profile
Invitae Corp
Country
Industry
Market Cap
Dividend Yield
Description
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. The company is headquartered in San Francisco, California and currently employs 3,000 full-time employees. The company went IPO on 2015-02-12. The firm is engaged in delivering genetic testing services that support a lifetime of patient care from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. These tests are delivered through a platform that serves patients, healthcare providers, biopharma companies and other partners, thereby capturing the potential of genetics and helping to expand its use across the healthcare continuum. The company offers Invitae Digital Health, a connected digital health platform that informs health decisions through actionable genomic insights for patients and clinicians. The firm offers genetic testing across multiple clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, personalized oncology, metabolic conditions, and rare diseases.
Contact
IPO
Employees
Officers
The intrinsic value of one
NVTA
stock under the Base Case scenario is
4.5
USD.
Compared to the current market price of 1.29 USD,
Invitae Corp
is
Undervalued by 71%.
